Hitech Kidney Care Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.40 M
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 147.33%
- Ebitda 128.18%
- Net Worth 3.18%
- Total Assets -14.33%
About Hitech Kidney Care
Hitech Kidney Care Private Limited (HKCPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2009 and has a history of 15 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.40 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Birla and Manjushri Birla serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100MH2009PTC197118
-
Company No.
197118
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hitech Kidney Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Birla
|
Director | 18-Nov-2009 | Current |
|
Manjushri Birla
|
Director | 18-Nov-2009 | Current |
Financial Performance of Hitech Kidney Care.
Hitech Kidney Care Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 147.33% increase in profit. The company's net worth moved up by a moderate rise of 3.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hitech Kidney Care?
In 2016, Hitech Kidney Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vaultrock Consultants LlpVivek Birla and Manjushri Birla are mutual person
-
Spectrum Superspeciality Hospitals Private Limited
Vivek Birla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hitech Kidney Care?
Hitech Kidney Care has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hitech Kidney Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hitech Kidney Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.